SCHEMBL2184752

SCHEMBL2184752

O=c1c2cc3c(=O)n(Cc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c(=O)c3cc2c(=O)n1Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
KDM4E B2RXH2 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
IDO1 P14902 2/20 0.40
JUN P05412 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
TSHR P16473 4/20 0.40
DAO P14920 2/20 0.39
CYP2D6 P10635 5/20 0.39
CYP3A4 P08684 5/20 0.39
USP2 O75604 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 2/20 0.38
MEN1 O00255 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12340322 0.87 MAPT (0.40) CA12CA1CA2CA9KDM4E
SCHEMBL2184970 0.84 CA12 (0.54) CA12CA1CA2CA9KDM4E
SCHEMBL12340315 0.82 CMA1 (0.42) CA12CA1CA2CA9KDM4E
SCHEMBL12340316 0.77 MAPT (0.52) CA12CA1CA2CA9KDM4E
SCHEMBL19660075 0.73 KDM4E (0.44) KDM4EHTTSMN1; SMN2TSHRCYP2D6
SCHEMBL12895972 0.73 SRC (0.50) CA12CA1CA2CA9KDM4E
SCHEMBL8734091 0.72 MGLL (0.52) KDM4EHTTSMN1; SMN2IDO1JUN
SCHEMBL55686 0.71 P2RX3 (0.49) CA12CA1CA2CA9KDM4E
SCHEMBL5531705 0.71 ADRB1 (0.40) CA12CA1CA2CA9KDM4E
SCHEMBL12150059 0.70 CA12 (0.56) CA12CA1CA2CA9DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8269215-B2 Pyromellitic diimide organic semiconductors and devices THE JOHNS HOPKINS UNIVERSITY (US) 2012-09-18 US disclosed
US-8269215-B2 Pyromellitic diimide organic semiconductors and devices THE JOHNS HOPKINS UNIVERSITY (US) 2012-09-18 US disclosed
US-20110163301-A1 PYROMELLITIC DIIMIDE ORGANIC SEMICONDUCTORS AND DEVICES THE JOHNS HOPKINS UNIVERSITY (US) 2011-07-07 US disclosed
US-20110163301-A1 PYROMELLITIC DIIMIDE ORGANIC SEMICONDUCTORS AND DEVICES THE JOHNS HOPKINS UNIVERSITY (US) 2011-07-07 US disclosed
WO-2010011658-A2 PYROMELLITIC DIIMIDE ORGANIC SEMICONDUCTORS AND DEVICES THE JOHNS HOPKINS UNIVERSITY (US) 2010-01-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110163301-A1 PYROMELLITIC DIIMIDE ORGANIC SEMICONDUCTORS AND DEVICES AQP4, FTO, KCNE1 CA12 452/4885CA1 893/4885CA2 359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.